Moving the Needle on Graft Rejection with Novel Strategies for T Cell Manipulation

Time: 12:30 pm
day: Day 1: Pre-Clinical & Translational - Morning

Details:

  • Exploring cell engineering to manipulate T-cells for elimination of the molecules responsible for rejection
  • Discussing how to use gene editing to simultaneously prevent rejection and enhance the function of the allogeneic T cell.
  • Incorporating new gene edits designed to avoid recognition by patient/host CD8+ T cells, CD4+ T cells and NK cells.

Speakers: